摘要
目的:明确人体血清血小板活化因子(PAF)及血小板活化因子乙酰水解酶(PAF-AH)水平与荨麻疹发病的相关性。方法:收集荨麻疹患者及正常对照者的血清样本,对荨麻疹患者进行病情严重程度评分(UAS),利用ELISA法对样本中PAF及PAF-AH水平进行测定。结果:共有32例急性和32例慢性荨麻疹患者入选,血清PAF水平分别为430.4 pg/mL及391.6 pg/mL,高于32例正常对照(224.5±31.67 pg/mL),差异均具有统计学意义(均P<0.05)。急、慢性荨麻疹患者血清PAF-AH水平与正常对照组相比无统计学差异。血清PAF水平与急、慢性荨麻疹患者UAS评分存在正相关(均P<0.05),PAF-AH水平与急、慢性荨麻疹病情严重程度评分均无明显相关性(均P>0.05)。结论:PAF可能与急、慢性荨麻疹的发病有关。
Objective: To determine the correlation of platelet-activating factor( PAF) and platelet-activating factor acetylhydrolase( PAF-AH) status in the patients with in acute/chronic urticaria. Methods: Serum samples from patients and normal controls were collected; Urticaria activity score( UAS) of the patients were assessed. The level of PAF and PAF-AH were detected by ELISA. Results: Thirty two patients with acute and 32 with chronic urticaria,and 32 normal controls were recruited into the study. The PAF level in the patients with acute urticaria and chronic urticaria were 430. 4 pg/mL and 391. 6 pg/mL respectively,which were higher than that in the controls( 224. 5 ± 31. 67 pg/mL),with significant differences( P < 0. 05). There were no significant difference of PAF-AH between urticaria patients and controls( P > 0. 05). Conclusion:PAF may be associated with the onset of urticaria.
引文
[1]朱奕锜,唐慧,王朵勤,等.维生素D与慢性荨麻疹的研究进展[J].国际皮肤性病学杂志,2017,43(4):223-226.
[2]陈佰超,李巍.荨麻疹的非IgE介导机制[J].国际皮肤性病学杂志,2016,42(3):188-191.
[3]张丽丹,刘炜钰,罗权.卢帕他定治疗荨麻疹的研究进展[J].皮肤性病诊疗学杂志,2016,23(5):362-364.
[4]Krause K,Giménezarnau A,Martinezescala E,et al.Platelet-activating factor(PAF)induces wheal and flare skin reactions independent of mast cell degranulation[J].Allergy,2013,68(2):256-258.
[5]林大东,庄美平,冉骞,等.变应性皮肤血管炎患者血浆血小板活化因子乙酰水解酶活性变化及其临床意义[J].临床军医杂志,2015,9:924-925.
[6]中华医学会皮肤性病学分会免疫学组.中国荨麻疹诊疗指南(2014版)[J].中华皮肤科杂志,2014,47(7):388-390.
[7]Palgan K,Bartuzi Z.Platelet activating factor in allergies[J].Int J Immunopathol,2015,28(4):584-589.
[8]Izaki S,Yamamoto T,Goto Y,et al.Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation[J].Br J Dermatol,1996,134(6):1060-1064.
[9]黄泓,陈红专.血小板活化因子的生物学效应和受体拮抗剂研究[J].上海交通大学学报(医学版),2005,25(1):89-92.
[10]姚新生.血小板活化因子的生理、病理作用及机制[J].临床与病理杂志,2002,22(4):374-376.
[11]Nakajima K,Murakami M,Yanoshita R,et al.Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor[J].J Biol Chem,1997,272(32):19708-19713.
[12]Church MK.Efficacy and tolerability of rupatadine at four times the recommended dose against histamine-and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males[J].Br J Dermatol,2010,163(6):1330-1332.
